Group 1 - Sanofi Bio (300298.SZ) released its 2024 annual report on April 21, 2025, with 203 institutional investors holding a total of 162 million shares, representing 28.65% of the total share capital [1] - The top ten institutional investors collectively hold 19.74% of the shares, with a decrease of 2.43 percentage points compared to the previous quarter [1] Group 2 - In the public fund sector, three funds increased their holdings, accounting for 0.12% of the total, while 17 funds decreased their holdings, representing a reduction of 1.63% [2] - A total of 177 new public funds were disclosed this period, including notable funds such as Southern CSI 1000 ETF and Huatai-PineBridge Innovation Medicine Mixed Fund [2] - One foreign fund, Hong Kong Central Clearing Limited, reduced its holdings by 0.20%, while UBS AG was not disclosed this period [2]
机构风向标 | 三诺生物(300298)2024年四季度已披露持股减少机构超10家